Lv3
296 积分 2024-11-04 加入
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
9个月前
已完结
Towards targeting the breast cancer immune microenvironment
1年前
已完结
Current and future immunotherapy for breast cancer
1年前
已完结
Role of Immunotherapy in Triple-Negative Breast Cancer
1年前
已完结
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options
1年前
已完结
皖公网安备34019202002308
